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Abstract 
Introduction: Chlordimeform, as well as other formamidine pesticides, has been described to induce permanent sex- and region-
dependent effects on development of monoaminergic neurotransmitter systems. The mechanisms that induce these effects are 
not known, but it has been suggested that these effects could be related to monoamine oxidase (MAO) inhibition. However, chlor-
dimeform is a very weak MAO inhibitor, which suggest that other mechanism should be involved. In this regard, formamidines, in 
general, and chlordimeform, in particular, alter the serum levels of steroid hormones, which regulate the expression of enzymes that 
mediate the synthesis and metabolism of monoaminergic neurotransmitters systems. Therefore, an alteration of these hormones in 
the brain could mediate the effects observed.
Objectives and methods: In order to confirm that the formamidines produce permanent alterations of the monoamine neurotrans-
mitter systems, through disruption of sex hormones in the brain, by alteration of the expression of the enzymes that synthesize and/
or metabolize these neurotransmitters, we evaluated, in frontal cortex of male and female rats, the effect on the levels of testostero-
ne and estradiol at 11 days of age, as well as the expression of MAO, COMT, BDH, TH, TRH, and AD enzymes at 60 days of age 
after maternal exposure to chlordimeform (5 mg/kg body weight).
Results: Chlordimeform induced a significant decrease in testosterone and estradiol levels in frontal cortex of rats at 11 days of 
age. We observed sex interaction with treatment in the content of T and E2. We determined a bigger increase in the expression of 
TH [35,66% (P<0,001)] and TRH [42,14% (P<0,001)] enzymes in males than in females. Chlordimeform treatment did not alter the 
expression of MAO, COMT, AD, BDH enzymes, but decreased the expression of the enzymes TRH TH in both males and females.
Conclusions: The present findings indicate that after maternal exposure to formamidines, in general, and chlordimeform, in parti-
cular, a permanent alteration of monoaminergic neurotransmitters, through alteration of the enzymes that synthetize these neuro-
transmitters, mediated by sex hormones disruption in frontal cortex is induced.
Keywords: Chlordimeform; formamidines; neurodevelopmental toxicity; TH; TRH; rats; human risk assessment 
Resumen
Introducción: Se ha descrito que el clordimeformo, así como otros plaguicidas formamidínicos, induce alteraciones permanentes 
de los sistemas de neurotransmisores monoaminérgicos región y sexo dependiente. Los mecanismos por los que se inducen es-
tos efectos no se conocen, pero se ha sugerido que podrían estar relacionados con la inhibición de la monoamino oxidasa (MAO). 
Sin embargo, el clordimeformo es un inhibidor muy débil de la MAO lo que sugiere que otro mecanismo debería estar implicado. 
En este sentido, se ha descrito que las formamidinas en general y el clordimeformo en particular, alteran los niéveles séricos de 
distintas hormonas las cuales regulan la expresión de las enzimas que sintetizan y metabolizan estos neurotransmisores. Por lo 
tanto, una alteración de estas hormonas a nivel cerebral podría mediar los efectos observados.
Objetivos y métodos: Con el objetivo de confirmar que las formamidinas produce alteraciones permanentes de los neurotrans-
misores monoaminérgicos, a través de la disrupción de las hormonas sexuales a nivel cerebral por alteración de la expresión de 
las enzimas que sintetizan y/o metabolizan estos neurotransmisores, se evaluaron los efectos, en la corteza frontal de ratas macho 
y hembra, sobre los niveles de testosterona y estradiol a los 11 días de edad, así como sobre la expresión de las enzimas MAO, 
COMT, BDH, TH , TRH, y AD a los 60 días de edad tras la exposición maternal al clordimeformo (5 mg/kg de peso corporal). 
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Introduction
Formamidine pesticides have been reported to induce 
permanent alteration of brain development. In this regard, 
the formamidine compound amitraz has been described 
to produce the induction of permanent alterations on the 
development of central nervous system (CNS) such as 
those that affect monoamine neurotransmitter systems1. 
Moreover, chlordimeform [N2-(4-chloro-o-tolyl)-N1.
N1-dimethylformamidine] (Figure 1), which is another 
member of formamidines family, has also been reported 
to induce permanent alterations of serotoninergic, no-
radrenergic and dopaminergic systems2,3. The mecha-
nism by which these effects occur is not known. 
Currently, it is assumed that the monoaminergic neuro-
transmitters play a role during development, defined as 
“morphogenetic” 4-7. Any change in the levels of catecho-
lamines during development could have a profound ef-
fect on brain development, both structural and function-
al8. In this sense, monoamine oxidase (MAO) inhibition 
was among the first biochemical actions of the formami-
dines to be reported9-10 and has been suggested as a 
possible mechanism of action, because neuronal MAO 
participates in metabolic inactivation of biogenic mono-
amines, which include the neurotransmitters serotonin 
(5-HT), norepinephrine (NE), and dopamine (DA). How-
ever, chlordimeform is a very weak MAO inhibitor, which 
suggest other mechanisms are involved in these effects. 
Alternatively, the changes in NE, DA and 5-HT and its me-
tabolites levels observed in rats’ brain after formamidines 
exposure could be attributed to a possible effect on sex 
steroid hormones that modulate the expression of en-
zymes such as tyrosine hydroxylase (TH), dopamine-β-hy-
droxylase (DBH), tryptophan hydroxylase (TRH), MAO, 
catechol-O-metyltransferase (COMT), aldehyde dehydro-
genase (AD), aldehyde reductase (AR) required for synthe-
sis and metabolism of these neurotransmitters11-18. In this 
regard, chlordimeform is an endocrine disruptor that alters 
prolactin and adrenocorticotropic hormones, among oth-
ers19, and amitraz alters testosterone and estradiol serum 
hormone levels in rats20. Therefore, if chordimeform, as 
well as other formamidine pesticides, alters sex hormones 
in the brains, this could mediate the effect observed on 
monoaminergic neurotransmitters systems.
According to all exposed above, we performed a study 
to establish if maternal exposure to formamidines during 
gestation and lactation induces permanent alterations on 
the enzymes that synthetize and metabolize 5-HT, NE and 
DA neurotransmitters in adult age, through sex hormones 
disruption. Chlordimeform was chosen because it is the 
most representative compound in its group, which pre-
sents a very low inhibition of MAO, allowing us to study 
more clearly whether the permanent changes observed on 
levels of these neurotransmitters are due to an alteration of 
the enzymes that catalyze the synthesis and metabolism of 
these neurotransmitter rather than inhibition of MAO.
This work focuses its interest in providing new data of for-
mamidines induced neurotoxicity during nervous system 
development, because new compounds of this family are 
being developed with therapeutic applications for which 
these effects are not considered in their risk assessment, 
which poses a potential health hazard.
Material and methods
Biological material 
All experiments were performed in accordance with Euro-
pean Union guidelines (2003/65/CE) and Spanish regu-
lations (BOE 67/8509-12, 1988) regarding the use of lab-
oratory animals. Eight pregnant Wistar rats were housed 
individually in polycarbonate cages and were assigned 
randomly to two experimental groups: a chlordimeform 
treatment group (n = 4) and a control group (n = 4).
    
Test Chemical and Treatment
Chlordimeform (Sigma, Madrid, Spain) was dissolved in 
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Resultados: El clordimeformo indujo una disminución significativa de los niveles de testosterona y estradiol en la corteza frontal de 
las ratas descendientes a la edad de 11 días. Se observó una interacción por sexo con el tratamiento en el contenido de T y E2. 
Además se observó una mayor expresión de las enzimas TH [35,66% (P<0,001)] y TRH [42,14% (P<0,001)] en los machos que 
en las hembras. El tratamiento con clodimeformo no alteró la expresión de las enzimas MAO, COMT, AD, BDH, pero disminuyó la 
expresión de las enzimas TH y TRH tanto en machos como en hembras.
Conclusiones: Los presentes resultados indican que las formamidinas, en general, y el clordimeformo, en particular, inducen, tras 
la exposición maternal, una alteración permanente de los sistemas de neurotransmisores monoaminergicos en la corteza frontal, a 
través de la alteración de las enzimas que sintetizan estos neurotransmisores, mediada por la alteración de las hormonas sexuales.
Palabras clave: Clordimeformo; formamidinas; neurotoxicidad en el desarrollo; testosterona; estradiol; TH, TRH, ratas; evaluación 
del riesgo para el hombre
Figure 1: Chlodimeform chemical structure (C10H13Cl N2).
Cl N= CH - N
CH3
CH3
CH3
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corn oil to provide fast and complete absorption and was 
administered orally by gavage in a volume of 2 mg/ml. 
The animals received daily chlordimeform at the dose of 
5 mg/kg on days 6 to 21 of pregnancy (GD 6-21) and on 
days 1 to 10 of lactation (PN 1-10). Control dams received 
vehicle (corn oil 2.5 ml/kg) on the same schedules. Dose 
of chlordimeform was selected based on a previous pre-
liminary study that indicated that this dose was the higher 
one that did not cause weight loss or mortality, reduction 
of food or water intake as well as did not induce haema-
tological modifications of other clinical histopathological 
signs of overt toxicity. None of the prenatal or postnatal 
treatment evoked a significant change in weight of any of 
the brain regions on PN 60 (data not shown).
Dams were examined daily throughout the gestation and 
lactation periods for mortality, general appearance and 
behaviour. The maternal body weights were measured 
on GD 1, GD 5, GD 6, GD 15 and GD 20. Food and wa-
ter consumption during pregnancy, length of gestation, 
litter size and sex ratio were also assessed. 
On PN1, all litters were examined externally, sexed and 
weighed. Litters were organized in groups of twenty-four 
pups, twelve males and twelve females. Litters were 
weighed at PN 1, PN 7, PN14 and PN 21. The offspring 
were weaned on lactation day 21 and were maintained 
in appropriate conditions, housed individually and with-
out any treatment with full access to food and water until 
adult age. The study was organized in treated groups of 
six males and six females randomly selected respec-
tively from the dams’ litters exposed to chlordimeform, 
and control groups of six males and six female’s pups 
randomly selected respectively from the control dams’ 
litters.
At PN11, for the analysis of testosterone and estradiol’s 
brain levels and at PN 60, for the analysis of MAO A, 
MAO B, COMT, BDH, AD, TH and TRH gene expres-
sion, male and female rats from control and treated 
groups (pups from control dams, and pups from dams 
exposed to chlordimeform, respectively) were sacrificed 
by decapitation. The brain was removed quickly and the 
frontal cortex was a rapidly dissected out at 4ºC21, since 
this brain region was previously describe to present sex 
differences in the effect observed on these neurotrans-
mitters systems and to be one of the most affected2,3. 
Tissues were rapidly weighed and stored at -80ºC until 
analysis. All data were collected by experimenters blind 
to the treatment condition of the offspring.
Estradiol and testosterone quantification
Estradiol and testosterone content were measured in 
prefrontal cortex from treated animals in order to deter-
mine whether sex hormones are altered by chlordime-
form exposure. Estradiol and testosterone content in the 
prefrontal cortex was measured using an enzyme immu-
noassay kit (Estradiol EIA Kit, Cayman Chemical Compa-
ny, MI, USA), according to the manufacturer’s instruction. 
Tissues were homogenized in 300 μl of an equal mixture 
of ethyl acetate and 0.1 M phosphate-buffered saline. 
The homogenates were centrifuged at 21,000 g for 15 
min at 4ºC. The resulting mixture was then incubated in 
a MeOH/dry ice bath to solidify the aqueous phase (bot-
tom) and the organic phase was eluted into a new tube. 
The ethyl acetate portion was collected and dried. The 
dried material was reconstituted in 120 μl EIA buffer, and 
100 μl of the sample was used for EIA at duplicate. ELI-
SA values were obtained (pg/ml) and corrected for weigh 
tissue (mg/ml), producing a final unit of pg/mg and pre-
sented as a percentage of the untreated control.
Real-time PCR analysis
The MAOA, MAOB, COMT, AD, TH, TRH and DBH ex-
pression was measured in frontal cortex tissue from con-
trol and chlordimeform treated animals in order to de-
termine whether chlordimeform, through sex hormones 
disruption, alters permanently the expression of these 
enzymes. Total RNA was extracted using the Trizol Re-
agent method (Invitrogen, Madrid, Spain). The final RNA 
concentration was determined using a Nanodrop 2000 
spectrophotometer (Thermo Fisher Scientific, Madrid, 
Spain), and the quality of total RNA samples was as-
sessed using an Experion LabChip (Bio-Rad, Madrid, 
Spain) gel. First-strand cDNA was synthesized with 1000 
ng of cRNA by using a PCR array first strand-synthesis kit 
(C-02; SuperArray Bioscience, Madrid, Spain) in accord-
ance with the manufacturer’s instructions and including 
a genomic DNA elimination step and external RNA con-
trols. After reverse transcription, QPCR was carried out 
using prevalidated primer sets (SuperArray Bioscience) 
for mRNAs encoding MAOA (PPR46359A), COMT 
(PPR06789A), AD (PPPR43520B), TH (PPR45220F), 
TRH (PPR48244A), DBH (PPR52652A), and ACTB 
(PPM02945B). ACTB was used as an internal control for 
normalization. Reactions were run on a CFX96 using Re-
al-Time SYBR Green PCR master mix PA-012 (Super-
Array Bioscience). The thermocycler parameters were 
95°C for 10 minutes, followed by 40 cycles of 95°C for 
15 seconds and 72°C for 30 seconds. Relative changes 
in gene expression were calculated using the Ct (cycle 
threshold) method. The expression data are presented 
as actual change multiples22. 
Data analysis
Statistical analysis of data was performed using a Stat-
graphics software, version Plus 4.1 for windows. Values 
are expressed as mean ± S.E.M. obtained from 12 an-
imals, six males and six females, in each group (control 
and treated groups). For values combined for males and 
females, a two-way ANOVA with treatment × sex interac-
tion was the initial test used. Where a significant treatment 
× sex interaction was detected, a separate Student’s t test 
was carried out for each sex. The results were considered 
significant at P<0.05. Results significantly different from 
controls are also presented as change from control (%).
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Results
Maternal and offspring body weight, physical and general 
activity development were unaffected by the exposure of 
dams to chlordimeform (5 mg/kg bw orally on days 6 to 
21 of pregnancy and 1 to 10 of lactation).
Estradiol and testosterone quantification
Oral treatment with chlordimeform to dams during the 
gestation period from day 6 to day 21 and during lacta-
tion from day 1 to day 10 affected the content of T and 
E2 in the region of frontal cortex of rats offspring at the 
age of 11 days. The content of T (ng/g tissue) in the 
region of frontal cortex in the control group and treated 
group is presented in table I. The content of E2 (ng/g 
tissue) in the region of the frontal cortex of the control 
group and the treated group is presented in table II. 
The results expressed in tables I and II show that in 
11 days old rats treated during gestation days 6-21 
and during lactation days 1-10 through their mothers, 
a statistically significant loss of E2 and T content in the 
frontal cortex compared to control animals was pro-
duced. A sex interaction with treatment in the content 
of T and E2 was observed (Figure 2). In frontal cortex 
the loss observed of E2 content was 46.53% (P <0.01) 
and 57.39% (P <0.001) in males and females, respec-
tively, and the loss in the content of T was 13.44% (P 
<0.001) and 20.70% (P <0.001) in males and females, 
respectively (Figure 2).
Real-time PCR analysis
Oral treatment with chlordimeform to dams during the 
gestation period from day 6 to day 21 and during lac-
tation from day 1 to day 10 affected the TH and TRH 
gene expression of rats offspring at the age of 60 days. 
In 60 days old rats treated during gestation days 6-21 
and during lactation days 1 to 10 a decrease in the ex-
pression of TH and TRH enzymes in frontal cortex with 
respect to control animals was observed. No effect on 
gene expression of MAO, COMT, BDH and AD enzymes 
was observed (Figure 3). A sex difference in TH and 
THR gen expression was observed, being higher the 
expression of TH [35,66% (P<0,001)] and THR [42,14% 
(P<0,001)] in males than females rats (Figure 4).
Table I: Tissue T (pg/ml) content determined in frontal cortex from male and female rats at 11 days of age treated with vehicle or chlordimeform (5 mg/kg bw orally on 
days 6 to 21 of pregnancy and 1 to 10 of lactation). 
Values are mean ± S.E.M.; control animals (n= 6 males, n= 6 females); treated group (n= 6 males, n= 6 females).
Statistical significance is reported for the ***P<0.001 levels compared with the control group.
Frontal Cortex
 Animal Control group Treated group Control group Treated group
  Males Males Females Females
 1 397,56 344,56 403,76 310,56
 2 401,45 348,62 395,91 321,65
 3 385,87 341,67 387,76 306,75
 4 396,74 338,59 389,56 311,39
 5 399,50 331,99 408,75 318,95
 6 388,71 345,81 401,64 323,84
 Mean ± 394,97±2,54*** 341,87±2,43*** 397,90±3,38*** 315,52±2,81***
 SEM  (-13,44%)  (-20,70)
Table II: Tissue E2 (pg/ml) content determined in frontal cortex from male and female rats at 11 days of age treated with vehicle or chlordimeform (5 mg/kg bw orally on 
days 6 to 21 of pregnancy and 1 to 10 of lactation). 
Values are mean ± S.E.M.; control animals (n= 6 males, n= 6 females); treated group (n= 6 males, n= 6 females).
Statistical significance is reported for the ***P<0.001 levels compared with the control group.
Frontal Cortex
 Animal Control group Treated group Control group Treated group
  Males Males Females Females
 1 132,56 73,98 128,65 55,44
 2 133,65 69,44 125,74 51,76
 3 136,59 64,32 131,78 48,87
 4 129,54 75,93 129,75 60,76
 5 128,65 72,59 134,87 57,53
 6 131,72 67,62 126,64 56,89
 Mean ± 132,12±1,17*** 70,65±1,76*** 129,57±1,38*** 55,21 ±1,74***
 SEM  (-46,53%)  (-57,39%)
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Figure 2: Tissue T and E2 (pg/ml) content determined in frontal cortex from male and female rats at 11 days of age treated with vehicle or chlordimeform (5 mg/kg bw 
orally on days 6 to 21 of pregnancy and 1 to 10 of lactation). 
Figure 3: Sex difference results from real-time PCR targeting MAO, COMT, BDH, AD, TH y TRH genes after chlordimeform treatment in male and female rats. MAO, 
COMT, BDH, AD, TH y TRH gene expression was compared to male rats results. Each bar represents mean ± SD of 6 samples. Levels were measured using QPCR. 
ACTB was used as an internal control. ***p ≤ 0.001,**p ≤ 0.01, significantly different from males.
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ters regulate brain development prior to assuming their 
roles as transmitters in the mature brain23-25, thus any 
circumstance that affects these neurotransmitters in the 
developing brain can alter the final structure and function 
of that brain. Since the endogenous levels of 5-HT, DA 
and NE are highly regulated by MAO, any change in this 
enzyme can profoundly affect the developing brain. In 
this regard, it has been reported that gestational expo-
sure to MAO inhibitors clorgyline and deprenyl produc-
Discussion
Developmental neurotoxicity involves alterations in be-
havior, neurohistology, neurochemistry and/or gross dys-
morphology of CNS occurring in the offspring, because 
of chemical exposure of dams during pregnancy or 
lactation. Previous studies described that formamidines 
induce permanent alteration in developing monoamine 
neurotransmitter systems1-3. The mechanism by which 
these permanent effects on monoaminergic systems 
take place is unknown, but monoamine neurotransmit-
Figure 4: Results from real-time PCR targeting MAO, COMT, BDH, AD, TH y TRH genes after chlordimeform treatment in male and female rats. MAO, COMT, BDH, 
AD, TH y TRH gene expression was compared to controls. Each bar represents mean ± SD of 6 samples. Levels were measured using QPCR. ACTB was used as an 
internal control. ***p ≤ 0.001, **p ≤ 0.01 significantly different from controls.
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es in offspring at 30 days of age, a significant reduc-
tion of serotonergic innervation particularly in the frontal 
cortex26, but not in the dopaminergic and noradrenergic 
innervation, which suggests that besides MAO inhibition 
other mechanism should be implicated in the alteration 
observed. However, chlordimeform is a very week MAO 
inhibitor27-29, but presents similar permanent regional and 
sexual dependent effects than amitraz, which is a potent 
MAO inhibitor9. These data suggest that MAO inhibition 
could not produce the alterations in monoaminergic neu-
rotransmitters systems observed, confirming that other 
mechanisms are involved. 
Otherwise, steroids play a role in the development of 
catecholamine systems30-33, and play a critical role in 
mammalian brain developmental of both genders34. The 
present study shows that prenatal and postnatal ex-
posure to chlordimeform (5 mg/kg bw orally on days 6 
to 21 of pregnancy and 1 to 10 of lactation) was not 
able to induce maternal toxicity, since during pregnancy 
maternal weight gain of treated rats was not modified. 
However, chlordimeform administered during pregnan-
cy and lactation leads to a decrease in T and E2 lev-
els at PN11, which is the critical period of time when 
sexual differentiation takes place, in males and females 
rats’ frontal cortex. This effect produced a permanent 
reduction of the TH and TRH gene expression, which 
catalyse the synthesis of monoaminergic neurotransmit-
ters, at 60 days of age in males and females rats’ fron-
tal cortex. Previously, chlordimeform has been reported 
to disrupt different steroids hormones19, which support 
the effect observed. The origin of the sex hormones in 
the brain, could be from gonads or from endogenous 
synthesis, as previously described, whose contribution 
to the final effect depends on the region and sex ster-
oid hormone35-38. Estradiol alters the levels of enzymes 
that synthesize DA, NE and 5HT, as well as those that 
degrade these neurotransmitters12,14,16,39-40. E2 elevat-
ed mRNA levels of TH, the first and major rate limiting 
enzyme in catecholamine biosynthesis40 and enhanced 
TRH mRNA expression12. In addition, T and DHT regu-
lated the synthesis and metabolism of monoamines17. 
In this sense, T and DHT increased TH protein and 
COMT, MAO-A and MAO-B mRNAs15. In the same way, 
DHT decreased neurotransmitter turnover of DOPAC/
DA, MHPG/NE, and 5-HIAA/5-HT of gonadectomized 
animals13. These previous data support the effects ob-
served on these enzymes after chlordimeform treatment, 
and so, on the monoaminergic neurotransmitters.
Furthermore, other possible mechanisms that may con-
tribute to the permanent alterations observed on mono-
aminergic neurotransmitters systems could be a direct 
action of chlordimeform on neuronal cell replication, 
differentiation, axonogenesis and synaptogenesis and 
functional development of neurotransmitter systems, ef-
fects that could result in behavioural alterations observed 
in previous studies after developmental exposure to 
chlordimeform41. The loss of dopaminergic, serotonin-
ergic and noradrenergic projections could also play an 
important role in the behavioural alterations. In this regard, 
frontal cortex participates in the regulation of learning and 
memory processes42-45, thus, it could be considered that 
these processes could be compromised by exposure 
during gestation and lactation to formamidines. In addi-
tion, the dysfunction in serotonin and dopamine systems 
are involved in appetite, affective, neuropsychiatric disor-
ders46-49, among others, which could also be induced by 
formamidine exposure during development. Further stud-
ies are needed to test whether these other mechanisms 
described could be involved in the effects observed and 
to confirm that alteration of these neurotransmitter sys-
tems is the cause of some of these dysfunctions.
Given that the DA, 5-HT and NE systems alterations 
observed after chlordimeform exposure in the frontal 
cortex, striatum, and hippocampus was similar between 
them2,3, and was also the same as those affected by 
amitraz1, it could be inferred that the alteration in the 
expression of these enzymes, mediated through sex 
hormones disruption, is the mechanism by which these 
monoaminergic neurotransmitters are altered in these 
brain regions by chlordimeform and formamidines in 
general. Further studies are needed to confirm whether 
this mechanism and others, probably involved in these 
effects, are the same in all brain regions studied and for 
all formamidines.
Conclusion
In summary, our results suggest that the mechanism by 
which the alterations in the development of the mono-
aminergic neurotransmitter systems in frontal cortex is 
mediated through disruption of estradiol and testoster-
one levels, which produced a permanent alteration of 
the expression of some of the enzymes that synthetize 
and metabolize these monoaminergic neurotransmit-
ters. Further studies are required to check whether other 
hormones are also involved in these effects and to de-
termine whether they act directly on expression of the 
affected enzymes or through induction of other genes 
that can regulate their expression. Otherwise, it should 
be determined whether there is a reduction in innerva-
tion in the regions affected that could also contribute to 
the effect observed. Due to the fact that monoaminer-
gic neurotransmitters dysfunctions are related with ap-
petite, affective, neurological and psychiatric disorders, 
behavioral studies of formamidines are also needed to 
clarify the outcomes of long-term alterations in these 
monoaminergic neurotransmitters systems. Currently, 
new molecules with therapeutic application are being 
developed as N-hydroxy-N-(4-butyl-2-methylphenyl) 
formamidine (HET0016) with protective effects against 
cardiovascular and cerebrovascular diseases. Until now, 
the risk assessment of the family of these compounds 
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The results reported in this study are of great importance 
and should be incorporated into the risk assessment of 
pesticides formamidines group.
Compliance with ethical standards
All experiments were performed in accordance with 
European Union guidelines (2003/65/CE) and Spanish 
regulations (BOE 67/8509-12, 1988) regarding the use 
of laboratory animals.
Conflict of interest
The authors declare that there are no conflicts of interest.
Acknowledgments
The authors would like to thank Miguel Capo and Marga-
rita Lobo, Professors of Toxicology from the Universidad 
Complutense de Madrid for their counseling during the 
preparation of the present work.
18 Medicina Balear 2017; 32 (1): 11-19
Javier del Pino et al. Effects of sex hormones disruption, after prenatal and postnatal exposure to chlordimeform, on monoaminergic neurotransmitters systems in female and male rat’s prefrontal cortex
21. Glowinski J, Iversen LL. Regional studies of catecholamines in 
the rat brain-I. The disposition of [3H] norepinephrine, [3H] dopamine 
and [3H]DOPA in various regions of the brain. J. Neurochem. 1966; 
13:655-69.
22. Livak KJ, Schmittgen TD. Analysis of relative gene expression data 
using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. 
Methods. 2001; 25: 402-8.
23. Whitaker-Azmitia PM. Role of serotonin and other neurotransmitter 
receptors in brain development: basis for developmental pharmacolo-
gy. Pharm. Rev. 1992; 43:553-61.
24. Di Pino G, Moessner R, Lesch KP, Lauder JM, Persico AM. Roles 
for serotonin in neurodevelopment: more than just neural transmission. 
Curr. Neuropharmacol. 2004; 2:403-17.
25. Ansorge MS, Morelli E, Gingrich JA. Inhibition of serotonin but 
not norepinephrine transport during development produces delayed, 
persistent perturbations of emotional behaviours in mice. J. Neurosci. 
2008; 28(1):199-207. 
26. Whitaker-Azmitia PM, Zhang X, Clarke C. Effects of gestational 
exposure to monoamine oxidase inhibitors in rats: preliminary beha-
vioral and neurochemical studies. Neuropsychopharmacology. 1994; 
11(2):125-32.
27. Neumann R, Voss G. MAO inhibition, an unlikely mode of action for 
chlordimeform. Experientia. 1977; 33: 23-4.
28. Robinson CP, Smith PW. Lack of involvement of monoamine oxi-
dase inhibition in the lethality of acute poisoning by chlordimeform. J 
Toxicol Environ Health. 1977; 3(3): 565-8.
29. Hollingworth RM. Chemistry, biological activity, and uses of forma-
midine pesticides. Environ Health Perspect. 1976; 14: 57-69.
30. Stewart J, Rajabi H. Estradiol derived from testosterone in prenatal 
life affects the development of catecholamine systems in the frontal 
cortex in the male rat. Brain Res. 1994; 646(1):157-60.
31. Leret ML, Rua C, Garcia-Montojo M, Lecumberri M, González JC. 
Influence of metyrapone treatment during pregnancy on the develop-
ment and maturation of brain monoaminergic systems in the rat. Acta 
Physiol (Oxf). 2009; 197(4):333-40.
32. Muneoka K, Kuwagata M, Ogawa T, Shioda S. Sex-specific effects 
of early neonatal progesterone treatment on dopamine and serotonin 
metabolism in rat striatum and frontal cortex. Life Sci. 2010; 87(23-
26):738-42.
33. Pappas SS, Tiernan CT, Behrouz B, Jordan CL, Breedlove SM, 
Goudreau JL, Lookingland KJ. Neonatal androgen-dependent sex 
differences in lumbar spinal cord dopamine concentrations and the 
number of A11 diencephalospinal dopamine neurons. J Comp. Neurol. 
2010; 518(13): 2423-36.
34. Konkle ATM, McCarthy MM. Developmental time course of estra-
diol, testosterone, and dihydrotestosterone levels in discrete regions of 
male and female rat brain. Neuroendocrinology. 2011; 152(1): 223-35.
35. Hojo Y, Higo S, Ishii H, Ooishi Y, Mukai H, Murakami G, Komina-
mi T, Kimoto T, Honma S, Poirier D, Kawato S. Comparison between 
hippocampus-synthesized and circulation-derived sex steroids in the 
hippocampus. Endocrinology. 2009; 150(11): 5106-12.
36. Robel P, Bourreau E, Corpéchot C, Dang DC, Halberg F, Clarke 
C, Haug M, Schlegel ML, Synguelakis M, Vourch C. Neuro-steroids: 
3 beta-hydroxy-delta 5-derivatives in rat and monkey brain. J Steroid 
Bioche. 1987; 27(4-6): 649-55.
37. Zwain IH, Yen SS. Dehydroepiandrosterone: biosynthesis and me-
tabolism in the brain. Endocrinology. 1999; 140(2):880-7.
38. Zwain IH, Yen SS. Neurosteroidogenesis in astrocytes, oligoden-
drocytes, and neurons of cerebral cortex of rat brain. Endocrinolo-
gy.1999; 140(8): 3843-52.
39. Luine VN, Khylchevskaya RI, McEwen BS. Effect of gonadal ste-
roids on activities of monoamine oxidase and choline acetylase in rat 
brain. Brain Res. 1973; 86: 293–306.
40. Serova L, Rivkin M, Nakashima A, Sabban EL. Estradiol stimulates 
gene expression of norepinephrine biosynthetic enzymes in rat locus 
coeruleus. Neuroendocrinology. 2002; 75: 193–200.
41. Olson KL, Boush GM, Matsumura F. Behavioral effects of perinatal 
exposure of chlodimeform in rats. Bull Environ Contam Toxicol. 1978; 
20(6):760-8.
42. Cifariello A, Pompili A, Gasbarri A. 5-HT (7) receptors in the modu-
lation of cognitive processes. Behav Brain Res. 2007; 195(1):171-9.
43. González-Burgos I, Feria-Velasco A. Serotonin/dopamine interac-
tion in memory formation. Prog Brain Res. 2008; 172:603-23.
44. Lapiz MD, Morilak DA. Noradrenergic modulation of cognitive 
function in rat medial prefrontal cortex as measured by attentional set 
shifting capability. Neuroscience. 2006; 137: 1039–49.
45. Dunnet SB, Meldrum A, Muir JL. Frontal-striatal disconnection dis-
rupts cognitive performance of the frontal-type in the rat. Neuroscience. 
2005; 135:1055–65.
46. Insel TR, Zohar J, Benkelf ATC, Murphy DL. Serotonin in obses-
sions, compulsions, and the control of aggressive impulses. Ann. N. Y. 
Acad. Sci. 1990; 600:574-85.
47. Stein DJ, Hollander E, Liebowitz MR. Neurobiology of impulsivity 
and the impulse control disorders. J. Neuropsychiatry Clin. Neurosci. 
1993; 5(1):9-17.
48. Riederer P, Sofic E, Konradi C, Kornhuber J, Beckmann H, Dietl M, 
Moll G, Herbenstreit G. The role of dopamine in control of neurobiologi-
cal functions. In: Fluckiger E, Muller EE, Thorner MO. (Eds.), Basic and 
Clinical Aspects of Neuroscience. The Role of Brain Dopamine. 1989. 
Springer. Berlin, pp. 1-17.
49. Kaye W. Neurobiology of anorexia and bulimia nervosa. Physiol 
Behav. 2008; 94:121-35.
19Medicina Balear 2017; 32 (1): 11-19
